| Pam-sue Schwartz, | |
|
200 Tyre Ave, Newark, DE 19711-7136 | |
| (302) 454-2047 | |
| (302) 454-5442 |
| Full Name | Pam-sue Schwartz |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 200 Tyre Ave, Newark, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104108588 | NPI | - | NPPES |
| 0000953367 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | U1-0000478 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pam-sue Schwartz, 200 Tyre Ave, Newark, DE 19711-7136 Ph: (302) 454-2047 | Pam-sue Schwartz, 200 Tyre Ave, Newark, DE 19711-7136 Ph: (302) 454-2047 |
News Archive
Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.
Semafore Pharmaceuticals today announced the presentation of data demonstrating that SF1126, a novel small molecule inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), has broad preclinical anti-tumor activity in multiple myeloma and lymphoma. Data were presented in a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C.
A new University of Colorado at Boulder study shows people have the ability to suppress emotional memories with practice, which has implications for those suffering from conditions ranging from post-traumatic stress disorder to depression.
› Verified 8 days ago
Mara L Sharp, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5442 | |
Elizabeth B Jones, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5443 | |
Stephanie Vantrease, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 E Chestnut Hill Rd, Newark, DE 19713 Phone: 302-985-3281 | |
Ellen Erin Latronico, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5442 | |
Samantha Fulton, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 99 Middleboro Rd, Newark, DE 19711 Phone: 302-992-5574 | |
Warna Warren, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 | |
Mrs. Gina Castiglione-jeandell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 212 Arrowwood Dr, Newark, DE 19713 Phone: 302-379-4329 |